Nicolas Gendron Shares A Great Example of How Climate Considerations Become Part of Medical Decision-Making
Nicolas Gendron, Research Fellow, Hematologist at Boston Children’s Hospital, shared on LinkedIn:
“Very pleased to see our work on the carbon footprint of direct oral anticoagulants featured in Le Quotidien du Médecin.
A great example of how climate considerations are now becoming part of medical decision-making, without compromising quality or safety of care. Let’s keep moving toward low-carbon healthcare.
Thank you Le Quotidien du Médecin for highlighting this work.
Original article in Haematologica Journal.”
Title: Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism
Authors: Laurence Chery, Zahra Hassani, Lise Durand, Dorothee Boisseau, Victorien Monguillon, David Grimaldi, Sebastien Taillemite, Benjamin de Sainte Marie, Nicolas Gendron
Also read.
Title: Dabigatran is 3 to 36 times more polluting than other DOACs, according to a French study.
Authors: Damien Coulomb
Never miss updates from Nicolas Gendron with Hemostasis Today.
-
Oct 19, 2026, 11:37Beth Faiman: APSHO Fellows Celebrated for Advancing Hematology and Oncology Practice
-
Oct 19, 2026, 11:26Emanuele Pacini: Myelodysplastic Syndromes Research Featured at JSH Annual Meeting in Kyoto
-
Oct 19, 2026, 10:57Jesmond Dalli: How Erythroblasts Shape Neutrophil Development and Function
-
Oct 19, 2026, 10:41Hisham Fahmi: SCD – Should Gene Editing Begin Before Organ Damage?
-
Oct 19, 2026, 10:33Pallavi Madhiraju: YARTEMLEA Faces Another European Rejection Despite FDA Approval
-
Oct 19, 2026, 10:28Brig Tathagata Chatterjee: Acute Leukemias in AYAs at the Japanese Society of Hematology Conference
-
Oct 19, 2026, 10:27Heather M. Johnson: Join the Discussion on Optimizing the CTEPH Diagnostic Pathway
-
Oct 19, 2026, 10:18Flora Peyvandi: Unravelling the Complexity of VWF Through Genetics
-
Oct 19, 2026, 09:55High DOAC Adherence in Patients With Ischemic Stroke and AF – International Journal of Stroke